본문 바로가기

Degradation of Polo-like Kinase 1 by the Novel Poly-Arginine N-Degron Pathway PROTAC Regulates Tumor Growth in Nonsmall Cell Lung Cancer

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
JOURNAL OF MEDICINAL CHEMISTRY67(5) · pp.3307 · 2024
피인용
Web of Science 26Scopus 26
FWCI (Scopus)
2.73
JCR IF
JCR 2023 6.9
ISSN
0022-2623

저자

  1. Gunasekaran, Pethaiah제1저자Korea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
  2. Hwang, Yeon SilKorea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
  3. Lee, Gong-HyeonDandicure Inc, Ochang 28119, Chungbuk, South Korea
  4. Park, JaehuiChungbuk Natl Univ, Coll Pharm, Cheongju 28160, Chungbuk, South Korea
  5. Kim, Jung GiKorea Res Inst Biosci & Biotechnol, Nucl Acid Therapeut Res Ctr, Cheongwon 28116, Chungbuk, South Korea
  6. La, Yeo KyungKorea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
  7. Park, Nam YeongKorea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
  8. Kothandaraman, RajeshDandicure Inc, Ochang 28119, Chungbuk, South Korea
  9. Yim, Min SuKorea Dis Control & Prevent Agcy, Natl Inst Hlth, Ctr Vaccine Res, Div Vaccine Dev Coordinat,Natl Inst Infect Dis, Cheongju 28159, South Korea
  10. Choi, JoonhyeokKorea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
  11. Kim, Hak NamKorea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
  12. Park, Il YeongChungbuk Natl Univ, Coll Pharm, Cheongju 28160, Chungbuk, South Korea
  13. Lee, Soo JaeChungbuk Natl Univ, Coll Pharm, Cheongju 28160, Chungbuk, South Korea
  14. 김미현교신저자Pusan Natl Univ, Dept Internal Med, Sch Med, Busan 49241, South Korea
  15. Cha-Molstad, Hyunjoo교신저자Korea Res Inst Biosci & Biotechnol, Nucl Acid Therapeut Res Ctr, Cheongwon 28116, Chungbuk, South Korea
  16. Shin, Song Yub교신저자Chosun Univ, Dept Cellular & Mol Med, Sch Med, Gwangju 61452, South Korea
  17. Ryu, Eun Kyoung교신저자Korea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
  18. Bang, Jeong Kyu교신저자Korea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea

초록

Polo-like kinase 1 (PLK1), which is crucial in cell cycle regulation, is considered a promising anticancer drug target. Herein, we present the N-degron pathway-based proteolysis targeting chimera (PROTAC) for PLK1 degradation, targeting the Polo-box domain (PBD). We identified DD-2 as the most potent PROTAC that selectively induces PLK1 degradation in cancer cells, including HeLa and nonsmall cell lung cancer (NSCLC), through the N-degron pathway. DD-2 exhibited significant in vitro anticancer effects, inducing G2/M arrest and apoptosis in HeLa and NSCLC cell lines. DD-2 showed significant tumor growth inhibition in a xenograft mouse model using HeLa and NSCLC cell lines, highlighting its potential in cancer treatment. Furthermore, the combination of DD-2 with tyrosine kinase inhibitor (TKI), osimertinib, effectively suppressed tumor growth in double-mutated H1975 cell lines, emphasizing DD-2’s potential in combination cancer therapies. Collectively, this study demonstrates the potential of the N-degron pathway, especially using DD-2, for targeted cancer therapies.

키워드

SMALL-MOLECULE INHIBITORE3 UBIQUITIN LIGASEEND RULE PATHWAYBOX DOMAINTARGETPLK1COMPLEXIDENTIFICATIONBI-2536BINDING

식별자

Scopus EID
2-s2.0-85180960077
WoS UID
001158875000001